Enhanced Recovery After Surgery (ERAS)Guidelines in Mitral Valve Surgeries, Questionnaire

Enhanced Recovery After Surgey (ERAS)Guidelines in Mitral Valve Surgeries, Questionnaire

ERAS after cardiac surgery is a well known protocol ,However the investigators study if it is applied at our institute

Study Overview

• Status: Recruiting
• Conditions: ERAS

Detailed Description

Enhanced recovery after surgery (ERAS) is a term that include a series of evidence-based perioperative care pathways designed to reduce physiological and psychological stress in surgical patients and to achieve rapid recovery.

In 2016, the first pilot study was published, which analyzed enhanced recovery after cardiac surgery (ERACS). Weaning from mechanical ventilation is considered one of the items that forms the concept of enhanced recovery in cardiac surgery.

Pain is an undesirable consequence of surgery especially cardiac surgery as pain during and following cardiac surgery has been shown to be a risk factor for increased morbidity. Systemic opioids have been the main stay for the management of perioperative pain in cardiac surgery. Lower doses of opioids has been related to early extubation and minimizing opioid-related side effects, such as prolonged ventilation, tolerance, nausea, vomiting, gut dysfunction, and immunosuppression.

On the other hand the investigators find cases of morbidity and mortality not related to the surgical procedure. ERAS protocol discuss the optimum condition that can be used to avoid the morbidity and mortality complications.

the investigators aim to know how well ERAS protocol is known and applied

• Study Type: Observational
• Enrollment (Estimated): 267

Contacts and Locations

• Study Contact: Name: sherif M Abbas, MD.; Phone Number: 0201141235049; Email: s25041989@hotmail.com

Study Locations

• Egypt
  • Cairo, Egypt
    • Recruiting
    • Cairo Unviersity
    • Contact: Sherif M Abbas, MD; Phone Number: 0201141235049; Email: s25041989@hotmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 25 years to 60 years (Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

• Anesthesia department, Cairo university hospitals, kasr al-ainy.
• Cardiothoracic thoracic surgery department, Cairo university hospitals, kasr al-ainy.
• Anesthesia department, National Heart Institute.
• Cardiothoracic surgery department, National Heart Institute.

Description

Inclusion Criteria:

• Cardiac anesthesiologists.
• Cardiac intensivists.
• Cardiothoracic surgeons.
• All stuff members from resident to consultant are included inside this study

Exclusion Criteria:

-

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Other

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
• Cardiac anesthesiologists • Cardiac intensivists • Cardiothoracic surgeons; Anesthesia department, Cairo university hospitals, kasr al-ainy.; Cardiothoracic thoracic surgery department, Cairo university hospitals, kasr al-ainy.; Anesthesia department, National Heart Institute.; Cardiothoracic surgery department, National Heart Institute.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Assessement of the knowledge of doctors to ERAS guidelines in cardiac surgery by using the grading system.	Assessement of the knowledge of doctors to ERAS guidelines in cardiac surgery by using the grading system.Grading system will be described as:-; Grade A ( knows well( : more than 60 % correct answer; Grade B ( fair ): 35 :60 % correct answer; Grade C ( knows nothing ) :- less than 35 % correct answer	6 months

Collaborators and Investigators

• Sponsor: Cairo University

Study record dates

Study Major Dates

• Study Start (Actual): November 20, 2022
• Primary Completion (Estimated): October 1, 2023
• Study Completion (Estimated): November 1, 2023

Study Registration Dates

• First Submitted: October 28, 2022
• First Submitted That Met QC Criteria: November 10, 2022
• First Posted (Actual): November 15, 2022

Study Record Updates

• Last Update Posted (Actual): August 30, 2023
• Last Update Submitted That Met QC Criteria: August 29, 2023
• Last Verified: August 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: MS-337-2022

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No